Locked Down or Left Exposed: Cannabis Data Risk After Rescheduling

Rescheduling has sparked more questions than answers, and operators are making decisions in a fog of speculation. This session cuts through the noise with a clear-eyed look at what a move to Schedule III genuinely changes for cannabis businesses, and what stays the same. 

The panelists will unpack the regulatory issues that hit your bottom line. They'll examine Section 280E tax implications, shifting banking access, DEA oversight, and FDA compliance requirements, with an honest assessment of timelines and open questions. Rather than chase headlines, the panelists will focus on the practical realities shaping cannabis market trends and the opportunities ahead. 

The hemp industry is approaching a challenging regulatory path. Pending federal and state enforcement deadlines aim to close the loophole that let intoxicating, hemp-derived products flourish, redefining legal hemp by total-THC content rather than delta-9 alone. For cultivators, retailers, and legal professionals, the stakes are immediate: products that pass today could be illegal overnight, stranding inventory and exposing operators to real liability. 

This session offers a perspective of what the cliff actually means for your business. The panelists will break down total-THC compliance challenges and tightening synthetic cannabinoid restrictions, then pinpoint the categories most exposed, including delta-8, THCA flower, and high-potency THC beverages. Grounded in current hemp industry trends and cannabis business compliance realities, this discussion moves past speculation to give you a defensible plan. You'll leave knowing how to pivot, protect margin, and turn disruption into cannabis industry opportunities before your competitors react. 

The 280E landscape is shifting faster than most operators can track, and the decisions you make now could mean recovering serious cash or leaving it on the table. This session translates recent 280E developments into clear, actionable tax strategy for cannabis business owners and tax professionals. 

The panelists will move past speculation to address the questions that hit your balance sheet directly. They'll examine amended return strategies, defensible COGS positioning, and how to identify open refund windows before they close. You'll get a grounded read on what current rulings permit, where the real risk sits, and how to align filings with cannabis business compliance expectations. 

Set against today's cannabis market trends, this discussion turns regulatory complexity into concrete decisions you can act on the moment you leave the room. Join this session to uncover the cannabis industry opportunities hidden in your tax position.